Your browser doesn't support javascript.
loading
Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study.
Iizumi, Sakura; Shimoi, Tatsunori; Tsushita, Natsuko; Bun, Seiko; Shimomura, Akihiko; Noguchi, Emi; Kodaira, Makoto; Yunokawa, Mayu; Yonemori, Kan; Shimizu, Chikako; Fujiwara, Yasuhiro; Tamura, Kenji.
Afiliação
  • Iizumi S; Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Shimoi T; Keio University Graduate School of Medicine, 160 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
  • Tsushita N; Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. tshimoi@ncc.go.jp.
  • Bun S; Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, 3-1-3 Hongoh, bunkyo-ku, Tokyo, 113-0033, Japan. tshimoi@ncc.go.jp.
  • Shimomura A; Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Noguchi E; Department of Pharmacy, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Kodaira M; Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Yunokawa M; Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Yonemori K; Department of Medical Oncology, Kodaira Hospital, 20-16 Sasameminamicho, Toda city, Saitama, 335-0035, Japan.
  • Shimizu C; Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Fujiwara Y; Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Tamura K; Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
BMC Cancer ; 17(1): 819, 2017 Dec 04.
Article em En | MEDLINE | ID: mdl-29202787
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Furanos / Cetonas / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Furanos / Cetonas / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão